Skip to main content
letter
. 2020 Jun 1;201(11):1441–1443. doi: 10.1164/rccm.202001-0093LE

Figure 2.

Figure 2.

Percentage improvement in the visual analog scale for symptoms of cough, dyspnea, and wheeze after benralizumab administration. The vertical dashed line indicates the time of benralizumab administration. The vertical solid line indicates the time of hospital discharge.